Quick Answer
LakeShore Biopharma Co., Ltd. reported Gross Profit of $70.66 million for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $70.66M | -84.5% |
| 2024 | $455.73M | -14.6% |
| 2023 | $533.84M | +38.3% |
| 2022 | $385.88M | +95.5% |
| 2021 | $197.36M | — |
- LakeShore Biopharma Co., Ltd. showed a decrease of -84.5% in Gross Profit compared to the prior fiscal year.
- Over the 2021–2025 period, LakeShore Biopharma Co., Ltd.’s gross profit has declined by 64.2% (from $197.36 million to $70.66 million).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: